The former vice president of business development for Israel-based Mazor Robotics Ltd. lost his post-trial bid for acquittal on insider trading charges after the court said a variance from the charged conduct was harmless.
The indictment charged Doron Tavlin and two others—Afshin Farahan and David Gantman—with conspiring to trade on nonpublic information about Medtronic, Inc.'s planned acquisition of Mazor.
According to prosecutors, Tavlin told Farahan about the nonpublic plans, and Farahan told his friend Gantman. The company was valued at $1.6 billion, and both Farahan and Gantman earned significant returns on their respective investments after the deal was publicly announced ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.